SCHEMBL8102601

SCHEMBL8102601

CC1(C)CCC(C)(C)c2cc(C(N)C(=O)Nc3ccc(C(=O)O)c(O)c3)ccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARG P13631 10/20 0.49
RARB P10826 9/20 0.49
RARA P10276 9/20 0.49
CYP26A1 O43174 5/20 0.47
KMT2A Q03164 4/20 0.47
CYP3A4 P08684 4/20 0.47
MEN1 O00255 3/20 0.47
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
TBXA2R P21731 1/20 0.47
BLVRB P30043 1/20 0.47
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
GRM1 Q13255 2/20 0.46
GRM2 Q14416 2/20 0.46
CYP2C9 P11712 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
RXRA P19793 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8839114 0.88 RARG (0.57) RARGRARBRARACYP26A1KMT2A
SCHEMBL8093046 0.84 RARB (0.64) RARGRARBRARACYP26A1KMT2A
SCHEMBL8103042 0.82 RARB (0.47) RARGRARBRARACYP26A1KMT2A
SCHEMBL8758241 0.81 RARB (0.46) RARGRARBRARACYP26A1KMT2A
SCHEMBL8093109 0.80 RARG (0.43) RARGRARBRARACYP26A1KMT2A
SCHEMBL8556007 0.80 RARB (0.50) RARGRARBRARACYP26A1KMT2A
SCHEMBL8102916 0.80 RARB (0.51) RARGRARBRARACYP26A1KMT2A
SCHEMBL7511656 0.78 RARA (0.77) RARGRARBRARACYP26A1KMT2A
SCHEMBL8906913 0.78 CYP26A1 (0.50) RARGRARBRARACYP26A1KMT2A
SCHEMBL8106316 0.78 CYP26A1 (0.44) RARGRARBRARACYP26A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US claimed
EP-0661260-B1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CIRD GALDERMA (FR) 1997-03-12 EP claimed
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed